iPSCs	Induced pluripotent stem cells
iPSC-CMs	Induced pluripotent stem cell-derived cardiomyocytes
SR	Sarcoplasmic reticulum
TT	Transverse tubule
E-C	Excitation-contraction coupling
CICR	Calcium-induced calcium release
NCX	Sodium/calcium exchanger
Na/K-ATPase	Sodium/potassium ATPase
InsP3R	Inositol triphosphate receptor
RyR2	Ryanodine receptor 2
BrS	Brugada syndrome
CPVT	Catecholaminergic polymorphic ventricular tachycardia
CASQ2	Calsequestrin 2
SQTS	Short QT syndrome
ICC	Inherited cardiac channelopathies
OSKM	Oct3/4, Sox2, Klf4 and c-Myc
LQTS	Long-QT syndrome
APD	Action potential duration
EADs	Early afterdepolarizations
DADs	Delayed afterdepolarizations
EHT	Engineered heart tissues
VUS	Variants of uncertain significance
CRISPRi/a	CRISPR-based interference and activation system
dCas9	Deactivated Cas9
ChR2	Channelrhodopsin
CTD	Calcium transient duration
EHM	Engineered heart muscle
T3	Triiodothyronine
Dex	Dexamethasone
NRVM	Neonatal rat ventricular cardiomyocytes
iPSC-CMs-ChR2	iPSC-CMs expressing Channelrhodopsin